Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.
about
Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene productNew developments in aminoglycoside therapy and ototoxicityEfflux-mediated drug resistance in bacteria: an updateAntibiotics that target protein synthesisStructural basis for the inhibition of bacterial multidrug exportersPhenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosaMexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factorMutations in PA3574 (nalD) lead to increased MexAB-OprM expression and multidrug resistance in laboratory and clinical isolates of Pseudomonas aeruginosaInvolvement of an ATP-dependent protease, PA0779/AsrA, in inducing heat shock in response to tobramycin in Pseudomonas aeruginosaPentachlorophenol induction of the Pseudomonas aeruginosa mexAB-oprM efflux operon: involvement of repressors NalC and MexR and the antirepressor ArmRMutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosaCharacterization of the Pseudomonas aeruginosa metalloendopeptidase, Mep72, a member of the Vfr regulonInduction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interactionEsrC, an envelope stress-regulated repressor of the mexCD-oprJ multidrug efflux operon in Pseudomonas aeruginosaFmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expressionGenetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsAminoglycoside resistance rates, phenotypes, and mechanisms of Gram-negative bacteria from infected patients in upper Egypt.Role of Vfr in regulating exotoxin A production by Pseudomonas aeruginosa.Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilmsCharacterization of a resistance-nodulation-cell division transporter system associated with the syr-syp genomic island of Pseudomonas syringae pv. syringae.Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy.Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.Synthesis and spectrum of the neoglycoside ACHN-490Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolatesDifferential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone-resistant Pseudomonas aeruginosaThe resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibilityEfflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Pseudomonas aeruginosa: resistance to the maxAmgRS-mediated envelope stress-inducible expression of the mexXY multidrug efflux operon of Pseudomonas aeruginosa.Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling.Efflux pump-mediated drug resistance in Burkholderia.Development and persistence of antimicrobial resistance in Pseudomonas aeruginosa: a longitudinal observation in mechanically ventilated patientsAminoglycoside resistance in Pseudomonas aeruginosa.Efflux-mediated antimicrobial resistance.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationRibosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa.Genome comparison analysis of molecular mechanisms of resistance to antibiotics in the Rickettsia genus.
P2860
Q24542408-CDAA82C5-3A60-48AE-958B-F78E89CC3868Q24599985-27DB17A2-4545-40D6-94E6-343F6A222F33Q24609407-EEBB7946-E357-465A-BF5A-1629661C8BE9Q27025271-A0EC151B-509E-4EE7-BBE4-E0EA44FF2348Q27685149-EF3E0994-3C0F-4D37-9610-8583B9FE6689Q28478449-B28D9C5A-F331-426D-A6AE-1B4874078771Q28492463-19EC92B9-7271-4D96-B3E5-DC6FC0C9D7E9Q28492484-F39AC8E2-DDE0-4416-8EF3-F17C8482646BQ28492485-544AD204-78BA-4C39-A5D5-0DDEB977347DQ28492564-42901704-8C7A-44CA-BC6F-4657F4655E3DQ28492617-C356BA86-0428-4044-A528-EA6B3D9E6F9AQ28492690-B8492D92-FEAE-47A4-8A36-D66BC9CA1775Q28492803-8B85D338-ED64-4882-B63C-BE2ACCA9D1D1Q28492825-AC54A3D2-80B8-4790-9DCE-F75529EE4562Q28492900-8287DA97-6B11-4EBA-BDED-063E55AB5E62Q29615301-FE715A59-D569-427F-8446-8570E8F010E2Q33831880-71EBCD56-DB30-44B8-A1F3-963865D7CF03Q33923007-C37DCB8B-D209-4BE6-9701-3B4649B971CDQ33935451-03D932F5-869C-4843-A4B1-42D373BD7F01Q33995877-776BE01A-6796-4ADE-BBE4-C88DB1CFBF15Q34117003-7F716E25-A1DB-4C98-9B4C-DF7C20B27DD0Q34117477-1AB696D1-0CBB-4D67-B820-2CC538E59206Q34134992-736E30D4-4D55-4368-80B1-F92703AF0783Q34269044-1FE5D1D4-BF63-403F-882B-55D60EFD104BQ34386310-27824AC9-4B37-4E1B-8A02-39F1962B1A05Q34648729-0A15268B-1BB9-4384-9B6A-8DE9AEA4B05EQ34680681-E216408A-862B-4C58-BA61-2ECF10F26E44Q34922676-BFCE3321-FB8B-4B38-A567-F4AE4AE46BE4Q34992258-6B2EB078-F598-4895-8AAB-4FE5D6AE474AQ35007624-0FC97A65-23E2-43C2-83D6-B363A685225AQ35084559-8EB79419-179A-485C-AD51-91ACBBB783D2Q35106217-D9EB461D-3D3C-40DB-9D7B-D40275C5558BQ35168882-D36D62A9-ABB2-48D7-BEE2-9A539FA3ADAEQ35407877-8F699CD8-7117-492A-AFAE-6DB7DB76A20EQ35758992-3440997E-37D3-4978-88C3-CC1B1A8E388EQ36021296-D609AA0B-42FB-4440-915B-DAB093680770Q36138147-5DA5202F-0362-4E90-A311-9312233A9156Q36295397-5FA221C2-6B23-417A-8874-F4B63E242DE5Q36313190-F2E2F33C-4C21-4967-BD30-C89CABC17056Q36397848-D499E0CD-906C-41D6-A1F4-9D2E7F1900F4
P2860
Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@en
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@nl
type
label
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@en
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@nl
prefLabel
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@en
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@nl
P2093
P2860
P1476
Contribution of the MexXY mult ...... aeruginosa clinical isolates.
@en
P2093
Geoffrey A McKay
Keith Poole
Mara L Sobel
P2860
P304
P356
10.1128/AAC.47.10.3202-3207.2003
P407
P577
2003-10-01T00:00:00Z